Sionna Therapeutics, Inc. (SION) financial statements and ratios from SEC XBRL: revenue $13.29M (TTM), net margin -566.1%, revenue growth 62.7% YoY. Income statement, balance sheet, cash flow, and valuation. First-party data.
| Revenue (TTM) | $13.29M |
| Net Margin | -566.1% |
| Revenue Growth (YoY) | 62.7% |
| EPS Growth (YoY) | -88.2% |
| FCF Growth (YoY) | 26.2% |
| Price / Book | 0.90 |
| Price / Sales | 20.39 |
| FCF Yield | -57.7% |
| Altman Z-Score | 6.33 (safe) |
| Sector P/E (Healthcare) | 21.7 |
SION overview · SION earnings · SION KPIs · SION investor relations · SION ownership · SION peers · SION filings
Data sourced from U.S. SEC EDGAR XBRL filings. Not personalized investment advice.